Leonteq Securities’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
Other funds holding TXG
Leonteq Securities's TXG Position: Q3 2026 in Review
Leonteq Securities increased its 10x Genomics (TXG) stake by 1,300% in Q3 2026, buying an estimated $23.6K and bringing the position to 434 shares worth $39.2K. The position accounts for ﹤0.01% of the portfolio, ranked #825.
Leonteq Securities first reported a position in TXG in Q1 2021 and has held it in 20 quarters since. The position peaked at $1.73M in Q2 2025. 389 funds tracked by Wall St. Rank hold TXG as of Q3 2026.
- Leonteq Securities held 434 shares of 10x Genomics worth $39.2K as of Q3 2026.
- Leonteq Securities bought 403 10x Genomics shares in Q3 2026, an estimated $23.6K.
- 10x Genomics made up ﹤0.01% of Leonteq Securities's portfolio in Q3 2026, its #825 holding.
- Leonteq Securities first reported a position in 10x Genomics in Q1 2021 and has held it in 20 quarters since.
- Leonteq Securities's 10x Genomics position peaked at $1.73M in Q2 2025.
- 389 funds tracked by Wall St. Rank held 10x Genomics as of Q3 2026.
Based on Leonteq Securities's 13F filing for Q3 2026, filed 29 Oct 2026.